Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 6777
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
IRBESARTAN HYDROCHLOROTHIAZIDE ZENTIVA 300MG/12,5MG TBL FLM 28
0028643 EU/1/06/377/018 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN HYDROCHLOROTHIAZIDE ZENTIVA 300MG/12,5MG TBL FLM 14
0028642 EU/1/06/377/017 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN HYDROCHLOROTHIAZIDE ZENTIVA 300MG/12,5MG TBL NOB 14
0028641 EU/1/06/377/006 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN HYDROCHLOROTHIAZIDE ZENTIVA 300MG/12,5MG TBL NOB 56X1
0028638 EU/1/06/377/009 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN HYDROCHLOROTHIAZIDE ZENTIVA 300MG/25MG TBL FLM 90
0193467 EU/1/06/377/034 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN HYDROCHLOROTHIAZIDE ZENTIVA 300MG/25MG TBL FLM 30
0193466 EU/1/06/377/033 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN HYDROCHLOROTHIAZIDE ZENTIVA 300MG/12,5MG TBL FLM 90
0193465 EU/1/06/377/032 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN HYDROCHLOROTHIAZIDE ZENTIVA 300MG/12,5MG TBL FLM 30
0193464 EU/1/06/377/031 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN HYDROCHLOROTHIAZIDE ZENTIVA 150MG/12,5MG TBL FLM 90
0193463 EU/1/06/377/030 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN HYDROCHLOROTHIAZIDE ZENTIVA 150MG/12,5MG TBL FLM 30
0193462 EU/1/06/377/029 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN HYDROCHLOROTHIAZIDE ZENTIVA 300MG/12,5MG TBL NOB 56
0028639 EU/1/06/377/008 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN HYDROCHLOROTHIAZIDE ZENTIVA 300MG/12,5MG TBL NOB 28
0028640 EU/1/06/377/007 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN MYLAN 300MG TBL NOB 500
0235388 58/ 070/12-C irbesartan.pdf irbesartan.pdf C09CA04 R
IRBESARTAN MYLAN 300MG TBL NOB 1000
0235389 58/ 070/12-C irbesartan.pdf irbesartan.pdf C09CA04 R
IRBESARTAN MYLAN 300 MG 300MG TBL NOB 60 I
0235390 58/ 070/12-C     C09CA04 B
IRBESARTAN MYLAN 300 MG 300MG TBL NOB 14 KAL I
0235391 58/ 070/12-C     C09CA04 B
IRBESARTAN MYLAN 300 MG 300MG TBL NOB 28 KAL I
0235392 58/ 070/12-C     C09CA04 B
IRBESARTAN MYLAN 300 MG 300MG TBL NOB 56 KAL I
0235393 58/ 070/12-C     C09CA04 B
IRBESARTAN MYLAN 300 MG 300MG TBL NOB 84 KAL I
0235394 58/ 070/12-C     C09CA04 B
IRBESARTAN MYLAN 300 MG 300MG TBL NOB 98 KAL I
0235395 58/ 070/12-C     C09CA04 B

‹‹ ‹ 50 60 70 80 90 96 97 98 99 100 101 102 103 104 105 106 110 120 130 140 150 200 300 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 24. November 2020 at 00:08
Last update of price and payment data: 31. October 2020 at 00:09